
Core Points - On August 27, the company Hualan Biological announced a semi-annual distribution plan for 2025, proposing a cash dividend of 5 yuan per 10 shares (including tax), with a total expected payout of 914 million yuan, representing 177.13% of net profit and a dividend yield of 3.08% based on the average trading price for the period [2][3][5] Financial Performance - For the first half of 2025, the company reported operating revenue of 1.798 billion yuan, an increase of 8.80% year-on-year, and a net profit of 516 million yuan, up 17.19% year-on-year, with basic earnings per share of 0.2824 yuan and a weighted average return on equity of 4.3% [3][4] Market Activity - On August 27, the stock experienced a net inflow of 58.25 million yuan from major funds, with a total net inflow of 169 million yuan over the past five days [4] - The latest margin financing balance for the stock is 1.456 billion yuan, with an increase of 51.46 million yuan over the past five days, reflecting a growth rate of 3.66% [5] Industry Comparison - Among the 53 companies in the pharmaceutical and biotechnology sector that announced semi-annual distribution plans for 2025, Hualan Biological ranks second in total cash payout, following WuXi AppTec, which announced a payout of 1.003 billion yuan [5]